Headquarters
2811 HILLSIDE DR, BURLINGAME, CA 94010-5958, US
BURLINGAME, CA, US
CORTENE INC
From the company
Cortene is a clinical stage biopharmaceutical company developing a patent-protected, peptide-based treatment for brain-centric acquired chronic diseases (ACDs). Its hypothesis centers on dysregulated serotonin signals driven by upregulated CRFR2, which it aims to reverse using agonist-mediated receptor endocytosis. The hypothesis has been partially proven in a proof-of-concept Phase 2 clinical trial, and the company plans trials in Parkinson's and Alzheimer's.
Products & services offered
Capabilities 4
Classifications
- Ownership classifications (2)
- Minority Owned Business, Subcontinent Asian American Owned
Facilities
Send your requirements
Quantities, certifications, and timing.